Quantcast

Latest Diabetic foot Stories

2010-08-02 19:29:51

People suffering from diabetes-related foot ulcers show different rates of healing according to the way they cope and their psychological state of mind, according to new research by a health psychologist at The University of Nottingham. The large study published in the journal Diabetologia this month has shown that the way patients cope with the condition and their levels of depression, affect how the wound heals or worsens. The work by Professor Kavita Vedhara from the University's Institute...

2010-07-13 06:00:00

ASHBURN, Va., July 13 /PRNewswire/ -- Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Technologies Ltd., has submitted a Special Protocol Assessment (SPA) for a proposed phase 3 clinical trial to support the U.S. approval of Cogenzia(TM): Innocoll's topical antibiotic therapy for the adjuvant treatment of infected diabetic foot ulcers. The protocol was developed following an End of Phase 2 meeting with FDA where the results of Innocoll's phase 2 clinical studies were...

2010-06-08 12:08:15

Study indicates that molecular imaging can help diagnose and determine treatment for a range of foot ailments common in diabetic patients A study presented at SNM's 57th Annual Meeting shows that using multiple imaging agents with a hybrid imaging technique can be a valuable tool for accurately diagnosing and determining treatment for a variety of diabetes-associated foot diseases. A common complication from Type 2 diabetes is the decreased ability to heal from even the most minor infections....

2010-05-26 16:11:00

ZUG, Switzerland and CANTON, Mass., May 26 /PRNewswire/ -- Organogenesis Switzerland GmbH will sponsor a symposium on Apligraf®, a bilayered living cellular construct for the treatment of chronic wounds and soft tissue repair, at the upcoming European Wound Management Association (EWMA) conference. This will be the first symposium ever held in Europe on the use of an allogeneic living cellular construct in the treatment of chronic wounds. At the symposium, titled...

2010-04-26 07:25:00

LOMBARD, Ill., April 26 /PRNewswire/ -- With over ten million diabetics in the U.S. alone and approximately 150,000 amputations performed yearly, inventor and American board-certified prosthetist John E. Rooney developed a custom-made ankle-foot orthosis with the trade name Ulcer Healing Orthosis(R) or UHO(R). The U.S. patented device helps to support the lower leg and foot, reducing mechanical stress on the bottom of the ulcerated foot. This allows blood flow to the ulceration, encouraging...

2010-04-15 07:00:00

ADDISON, Texas, April 15 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU) announced today that the company will present clinical evidence at the 2010 joint annual meeting of the Symposium on Advanced Wound Care and the Wound Healing Society (SAWC/WHS) in Orlando, Florida, April 17-20. SAWC/WHS is the premier wound care educational program within this clinical field and is the largest annual gathering of wound care clinicians in the United States. More than 2,000 physicians,...

2010-03-23 09:34:00

ADDISON, Texas, March 23 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU) announced that it sponsored a Wound Dressing Workshop at the 2010 Diabetic Foot Global Conference. Attendees of the Diabetic Foot Global Conference (DFCon) in Hollywood, California on March 20, 2010 participated in a hands-on workshop where they were trained in "best clinical practice" for Altrazeal(TM). Participants learned application techniques, clinical endpoints, and methods for treating different wound...

2010-03-17 12:52:00

LAKE CHARLES, La., March 17 /PRNewswire/ -- Everyone has heard of Botox being used to reduce the appearance of fine lines and wrinkles, but now the muscle-immobilizing treatment is moving to the opposite end of the body to get patients back on their feet. Craig Morton, MD, and Tyson Green, DPM, with the Center for Orthopaedics in Lake Charles, Louisiana, are successfully using Botox for patients with conditions ranging from diabetic foot ulcers to cerebral palsy. "Because of the...

2010-01-05 08:15:00

SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced plans to launch a new premium advanced skin care product line to promote foot health and comfort for podiatry patients. Cardium's new MedPodium(TM) product line is an over-the-counter product portfolio for patients with the potential for foot disorders and ailments. MedPodium represents a new line of foot care products to broaden and complement Cardium's Excellagen topical gel product...

2009-12-16 11:10:00

SAN DIEGO, Dec. 16 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported on recent clinical findings published in the December issue of Diabetes Care showing an increase in mortality in diabetic patients with a history of foot ulcer (HFU) compared with diabetic patients without HFU and with non-diabetic patients. (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ) The study titled, "A history of foot ulcer increases mortality among persons with...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related